Orbus Therapeutics Expands Series A Financing to $71 Million to Support Ongoing STELLAR Phase 3 Study in Rare Brain Cancer by Seini Moimoi | Oct 22, 2020 | Portfolio News
Akebia Presents Results from its INNO2VATE Global Phase 3 Program; Demonstrated Efficacy and Cardiovascular Safety of Vadadustat for the Treatment of Anemia due to Chronic Kidney Disease in Adult Patients on Dialysis by Seini Moimoi | Oct 22, 2020 | Portfolio News
Eargo, Inc. Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares by Seini Moimoi | Oct 20, 2020 | Portfolio News
Axonics® Launches ARTISTRY Study to Collect and Analyze Real-World Data of Patients Implanted with the Axonics r-SNM System by Seini Moimoi | Oct 20, 2020 | Portfolio News
Aptinyx Announces Proposed Public Offering of Common Stock by Seini Moimoi | Oct 20, 2020 | Portfolio News
